Table 3.
Characteristics | Healthy (n=80) | Low-risk (n=31) | High-risk (n=54) | Stage I (n=32) | Stage II (n=38) | Stage III (n=50) | Stage IV (n=35) | Chi square value/ t value | p Value |
---|---|---|---|---|---|---|---|---|---|
Gender | 1.403 | 0.966 | |||||||
No. of male (%) | 47 (23.7) | 19 (9.6) | 32 (16.2) | 19 (9.6) | 25 (12.6) | 33 (16.7) | 23 (11.6) | ||
No. of female (%) | 33 (27.0) | 12 (9.8) | 22 (18.0) | 13 (10.7) | 13 (10.7) | 17 (13.9) | 12 (9.8) | ||
Age (yr) | 51.19 ±12.53 | 56.58 ±11.73 | 54.13 ±10.37 | 57.03 ±10.21 | 60.50 ±13.23 | 57.40 ±12.05 | 57.77 ±12.76 | 3.521 | 0.002 |
Hcy (μmol/L) | 11.17 ±2.67a | 13.12 ±3.25b | 13.97 ±3.40b | 14.45 ±4.65b | 16.64 ±4.70c,d | 17.19 ±5.47d | 19.15 ±5.21e | 21.893 | <0.001 |
Values with a different superscript letter (a, b, c, d, e) have statistically significant differences between the groups. P<0.05.